Enliven Therapeutics, Inc. insider trading activity
Understanding Insider Activity at Enliven Therapeutics, Inc.
Welcome to our dedicated page for Enliven Therapeutics, Inc. (Nasdaq: ELVN) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Enliven Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Enliven Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for ELVN| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| ELVN | 10:04:43 PM 10/30/2024 | Hohl Benjamin(CHIEF FINANCIAL OFFICER) sold 6250 shares of Enliven Therapeutics, Inc. (ELVN) for ~$178465 | Filing |
| ELVN | 8:23:09 PM 10/22/2024 | Patel Anish(CHIEF OPERATING OFFICER) sold 716 shares of Enliven Therapeutics, Inc. (ELVN) for ~$21480 | Filing |
| ELVN | 8:22:14 PM 10/22/2024 | Lyssikatos Joseph P(CHIEF SCIENTIFIC OFFICER) sold 847 shares of Enliven Therapeutics, Inc. (ELVN) for ~$25410 | Filing |
| ELVN | 8:21:10 PM 10/22/2024 | Kintz Samuel(PRESIDENT AND CEO) sold 924 shares of Enliven Therapeutics, Inc. (ELVN) for ~$27720 | Filing |
| ELVN | 8:19:58 PM 10/22/2024 | Hohl Benjamin(CHIEF FINANCIAL OFFICER) sold 814 shares of Enliven Therapeutics, Inc. (ELVN) for ~$24420 | Filing |
| ELVN | 8:18:56 PM 10/22/2024 | Heyman Richard A. sold 1570 shares of Enliven Therapeutics, Inc. (ELVN) for ~$47100 | Filing |
| ELVN | 8:17:41 PM 10/22/2024 | Collins Helen Louise(CHIEF MEDICAL OFFICER) sold 816 shares of Enliven Therapeutics, Inc. (ELVN) for ~$24480 | Filing |
| ELVN | 9:06:43 PM 10/17/2024 | Heyman Richard A. sold 1270 shares of Enliven Therapeutics, Inc. (ELVN) for ~$35140 | Filing |
| ELVN | 12:39:48 AM 10/11/2024 | Lyssikatos Joseph P(CHIEF SCIENTIFIC OFFICER) sold 51145 shares of Enliven Therapeutics, Inc. (ELVN) for ~$1437564 | Filing |
| ELVN | 12:38:22 AM 10/11/2024 | Kintz Samuel(PRESIDENT AND CEO) sold 29977 shares of Enliven Therapeutics, Inc. (ELVN) for ~$841218 | Filing |
| ELVN | 12:36:22 AM 10/11/2024 | Ballal Rahul D. sold 10420 shares of Enliven Therapeutics, Inc. (ELVN) for ~$293531 | Filing |
| ELVN | 10:58:25 PM 10/8/2024 | Lyssikatos Joseph P(CHIEF SCIENTIFIC OFFICER) sold 10229 shares of Enliven Therapeutics, Inc. (ELVN) for ~$281670 | Filing |
| ELVN | 10:57:19 PM 10/8/2024 | Kintz Samuel(PRESIDENT AND CEO) sold 14936 shares of Enliven Therapeutics, Inc. (ELVN) for ~$410862 | Filing |
| ELVN | 10:56:05 PM 10/8/2024 | Hohl Benjamin(CHIEF FINANCIAL OFFICER) sold 11488 shares of Enliven Therapeutics, Inc. (ELVN) for ~$316034 | Filing |
| ELVN | 10:54:49 PM 10/8/2024 | Heyman Richard A. sold 2825 shares of Enliven Therapeutics, Inc. (ELVN) for ~$77715 | Filing |
| ELVN | 10:47:17 PM 10/3/2024 | Lyssikatos Joseph P(CHIEF SCIENTIFIC OFFICER) sold 527 shares of Enliven Therapeutics, Inc. (ELVN) for ~$14513 | Filing |
| ELVN | 10:45:58 PM 10/3/2024 | Kintz Samuel(PRESIDENT AND CEO) sold 526 shares of Enliven Therapeutics, Inc. (ELVN) for ~$14486 | Filing |
| ELVN | 10:44:54 PM 10/3/2024 | Hohl Benjamin(CHIEF FINANCIAL OFFICER) sold 521 shares of Enliven Therapeutics, Inc. (ELVN) for ~$14348 | Filing |
| ELVN | 10:43:46 PM 10/3/2024 | Heyman Richard A. sold 518 shares of Enliven Therapeutics, Inc. (ELVN) for ~$14265 | Filing |
| ELVN | 11:53:21 PM 10/1/2024 | Hohl Benjamin(CHIEF FINANCIAL OFFICER) sold 6250 shares of Enliven Therapeutics, Inc. (ELVN) for ~$153807 | Filing |
| ELVN | 8:17:36 PM 9/18/2024 | Heyman Richard A. sold 1270 shares of Enliven Therapeutics, Inc. (ELVN) for ~$28460 | Filing |
| ELVN | 9:43:58 PM 9/3/2024 | Lyssikatos Joseph P(CHIEF SCIENTIFIC OFFICER) sold 12000 shares of Enliven Therapeutics, Inc. (ELVN) for ~$269790 | Filing |
| ELVN | 10:36:36 PM 8/29/2024 | Hohl Benjamin(CHIEF FINANCIAL OFFICER) sold 4250 shares of Enliven Therapeutics, Inc. (ELVN) for ~$95795 | Filing |
| ELVN | 11:48:07 PM 8/28/2024 | Kintz Samuel(PRESIDENT AND CEO) sold 12000 shares of Enliven Therapeutics, Inc. (ELVN) for ~$274680 | Filing |
| ELVN | 11:49:46 PM 8/19/2024 | Heyman Richard A. sold 1270 shares of Enliven Therapeutics, Inc. (ELVN) for ~$29527 | Filing |
Discover the Complete Picture 🔒
Currently viewing just 6 of 99 insider filings.
Register now to dive deeper and explore the full dataset.